{"id":"https://openalex.org/W2763515255","doi":"https://doi.org/10.1093/annonc/mdx362.065","title":"OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm)","display_name":"OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm)","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2763515255","doi":"https://doi.org/10.1093/annonc/mdx362.065","mag":"2763515255"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdx362.065","doi":"https://doi.org/10.1093/annonc/mdx362.065","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx362.065","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)37577-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(20)37577-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087121536","display_name":"Andrew N.J. Tutt","orcid":"https://orcid.org/0000-0001-8715-2901","observed_orcids":["https://orcid.org/0000-0001-8715-2901"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I2799938689","display_name":"Breast Cancer Now","ror":"https://ror.org/02qa92s63","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2799938689"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Tutt","raw_affiliation_strings":["Breast Cancer Now Research Unit, Division of Cancer Studies, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Now Research Unit, Division of Cancer Studies, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I2799938689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050390557","display_name":"Bella Kaufman","orcid":"https://orcid.org/0000-0002-4236-3374","observed_orcids":["https://orcid.org/0000-0002-4236-3374"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"B. Kaufman","raw_affiliation_strings":["Breast Medical Oncology, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Medical Oncology, Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Garber","raw_affiliation_strings":["Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040290360","display_name":"Richard D. Gelber","orcid":"https://orcid.org/0000-0001-8270-8712","observed_orcids":["https://orcid.org/0000-0001-8270-8712"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Gelber","raw_affiliation_strings":["Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047139226","display_name":"Eleanor T. Mcfadden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. McFadden","raw_affiliation_strings":["Statistics, Frontier Science, Inverness, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, Frontier Science, Inverness, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000419121","display_name":"Carsten Dietrich Goessl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Goessl","raw_affiliation_strings":["Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088697304","display_name":"Giuseppe Viale","orcid":"https://orcid.org/0000-0003-1882-7068","observed_orcids":["https://orcid.org/0000-0003-1882-7068"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Viale","raw_affiliation_strings":["Medical School Pathology, Istituto Europeo di Oncologia, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School Pathology, Istituto Europeo di Oncologia, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063504632","display_name":"Charles E. Geyer","orcid":"https://orcid.org/0000-0002-2379-5702","observed_orcids":["https://orcid.org/0000-0002-2379-5702"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Geyer","raw_affiliation_strings":["Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107832821","display_name":"Dimitrios Zardavas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"D. Zardavas","raw_affiliation_strings":["Breast International Group, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013337676","display_name":"Amal Arahmani","orcid":"https://orcid.org/0009-0005-3752-9957","observed_orcids":["https://orcid.org/0009-0005-3752-9957"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A. Arahmani","raw_affiliation_strings":["Breast International Group, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006092979","display_name":"Debora Fumagalli","orcid":"https://orcid.org/0000-0002-0649-1942","observed_orcids":["https://orcid.org/0000-0002-0649-1942"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"D. Fumagalli","raw_affiliation_strings":["Breast International Group, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081663693","display_name":"Evandro de Azambuja","orcid":"https://orcid.org/0000-0001-9501-4509","observed_orcids":["https://orcid.org/0000-0001-9501-4509","https://orcid.org/0000-0001-7563-0179"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"E. De Azambuja","raw_affiliation_strings":["Breast International Group, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015067084","display_name":"Noam Falbel Ponde","orcid":"https://orcid.org/0000-0003-4016-0407","observed_orcids":["https://orcid.org/0000-0003-4016-0407"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"N. Ponde","raw_affiliation_strings":["Breast International Group, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043731313","display_name":"Pia Maarit Herbolsheimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Herbolsheimer","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W. Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Wu","raw_affiliation_strings":["Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074524828","display_name":"John P. Constantino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162619","display_name":"NRG Oncology","ror":"https://ror.org/050draa26","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210162619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Constantino","raw_affiliation_strings":["Statistics, NRG Oncology, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, NRG Oncology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4210162619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002068827","display_name":"Priya Rastogi","orcid":"https://orcid.org/0000-0002-6179-6407","observed_orcids":["https://orcid.org/0000-0002-6179-6407"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Rastogi","raw_affiliation_strings":["Division of Hematology/Oncology, Univ. of Pittsburgh Schools of the Health Sciences, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Univ. of Pittsburgh Schools of the Health Sciences, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.8191,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.74616026,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"28","issue":null,"first_page":"v67","last_page":"v67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9470000267028809},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/germline-brca1-2-mutation","display_name":"germline BRCA1/2 mutation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/high-risk-breast-cancer","display_name":"high-risk breast cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9280908107757568},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.6982189416885376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6912325620651245},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6674544215202332},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6011372208595276},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.5301802158355713},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.5227194428443909},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4799376130104065},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41002801060676575},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3458419442176819},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdx362.065","doi":"https://doi.org/10.1093/annonc/mdx362.065","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx362.065","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)37577-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdx362.065","doi":"https://doi.org/10.1093/annonc/mdx362.065","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx362.065","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)37577-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2763515255.pdf","grobid_xml":"https://content.openalex.org/works/W2763515255.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3167171623","https://openalex.org/W2622347503","https://openalex.org/W2341702212","https://openalex.org/W1620864007","https://openalex.org/W4415941470","https://openalex.org/W4411290166","https://openalex.org/W7204088122","https://openalex.org/W2887694024","https://openalex.org/W7129768919","https://openalex.org/W2761005087"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2017-10-20T00:00:00"}